SEC Form 4 · accession 0001144204-18-058924
MUSTANG BIO, INC. · MBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam J. Chill
Director
Period of report
Jun 14, 2018
Accepted (ET)
Nov 13, 2018 · 6:37 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001680048
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jun 14, 2018 | A | 10,000 | $0.00 | A | 60,000 | D | |
| COMMON STOCKF1,F2 | Nov 8, 2018 | A | 2,000 | $5.34 | A | 62,000 | D | |
| COMMON STOCKF1 | Nov 12, 2018 | A | 1,000 | $4.85 | A | 63,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F160,000 shares are restricted Common Stock which vest over various time periods.
- F2Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 8, 2018, was $4.90 to $6.06. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.